Characterization of peptide-amphiphiles possessing cellular activation sequences.
about
Supramolecular nanostructures that mimic VEGF as a strategy for ischemic tissue repairNanofibers and their applications in tissue engineeringUsing fluorogenic peptide substrates to assay matrix metalloproteinases.Cu(2+)-RGDFRGDS: exploring the mechanism and high efficacy of the nanoparticle in antithrombotic therapySelf-assembling glucagon-like peptide 1-mimetic peptide amphiphiles for enhanced activity and proliferation of insulin-secreting cellsDevelopment of a solid-phase assay for analysis of matrix metalloproteinase activity.Targeted drug delivery utilizing protein-like molecular architecture.Identification of specific hemopexin-like domain residues that facilitate matrix metalloproteinase collagenolytic activity.Synthesis and biological applications of collagen-model triple-helical peptides.Post-assembly functionalization of supramolecular nanostructures with bioactive peptides and fluorescent proteins by native chemical ligation.Bioactive supramolecular peptide nanofibers for regenerative medicine.Determining the Substrate Specificity of Matrix Metalloproteases using Fluorogenic Peptide Substrates.Selective modulation of matrix metalloproteinase 9 (MMP-9) functions via exosite inhibition.Induction of endothelial cell activation by a triple helical alpha2beta integrin ligand, derived from type I collagen alpha1(I)496-507.Stabilization of collagen-model, triple-helical peptides for in vitro and in vivo applications.Microwave-assisted synthesis of triple-helical, collagen-mimetic lipopeptides.MAPLE activities and applications in gas sensorsBiological, Chemical, and Electronic Applications of Nanofibers
P2860
Q34205393-7270655D-6B35-430F-A611-9F7E8C26CFC2Q34667748-D278C9FD-42E9-477E-9A54-00060137F242Q35162671-14D03D97-5413-4D49-84D0-D193A20F7429Q35508318-0A58B70C-345D-4F80-BD79-FE55785CDC62Q35857021-4EAC8B58-F42E-4F18-A40B-9062930F42F0Q36537240-44F50A03-5CAF-4DD3-B948-9C078425169BQ36846806-EAA3C54D-3CCC-4554-93EA-80D320CDA08DQ37433262-4EF9DB4C-0C54-42FF-AF03-ACB2396D3FD9Q37632930-4145DA34-C0DB-4650-B524-7ED4BA6BBC14Q37714137-6BA7EAB7-CEFC-41D4-9827-A12D0811A2BAQ38191528-3E2FC103-DCFA-4414-8ECF-593401D348D2Q38432629-6EDC7BA9-5C36-43CB-AD8C-20F285D6ECA4Q40089357-33B251D3-1CB1-460C-A702-C589207315E4Q40622330-1E9F4D90-0DCF-4D46-8198-5832F28B4A4CQ42548585-1C6D5D34-BD40-4185-BE47-06F57A48CE5EQ43199678-FB1B9AAD-3544-483D-9C33-E6FBF22088B0Q57346841-E7C7E796-5833-44D5-861E-DD106FE1AB2CQ59032489-60B15C40-7F82-4D06-93E0-D4937005D403
P2860
Characterization of peptide-amphiphiles possessing cellular activation sequences.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Characterization of peptide-amphiphiles possessing cellular activation sequences.
@ast
Characterization of peptide-amphiphiles possessing cellular activation sequences.
@en
Characterization of peptide-amphiphiles possessing cellular activation sequences.
@nl
type
label
Characterization of peptide-amphiphiles possessing cellular activation sequences.
@ast
Characterization of peptide-amphiphiles possessing cellular activation sequences.
@en
Characterization of peptide-amphiphiles possessing cellular activation sequences.
@nl
prefLabel
Characterization of peptide-amphiphiles possessing cellular activation sequences.
@ast
Characterization of peptide-amphiphiles possessing cellular activation sequences.
@en
Characterization of peptide-amphiphiles possessing cellular activation sequences.
@nl
P2093
P356
P1433
P1476
Characterization of peptide-amphiphiles possessing cellular activation sequences.
@en
P2093
Darius Juska
Gregg B Fields
Janelle L Lauer-Fields
Navdeep B Malkar
P304
P356
10.1021/BM0256597
P577
2003-05-01T00:00:00Z